TNYA – tenaya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones
Tenaya Therapeutics (NASDAQ:TNYA) was given a new $2.00 price target on by analysts at Morgan Stanley.
Tenaya Therapeutics (NASDAQ:TNYA) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Tenaya Therapeutics (TNYA) Is Down 39.7% After Cardiac Gene Therapy Milestones And $60M Fundraise - What's Changed [Yahoo! Finance]
Tenaya Therapeutics (NASDAQ:TNYA) had its price target lowered by analysts at HC Wainwright from $5.00 to $3.00. They now have a "buy" rating on the stock.
Form 8-K Tenaya Therapeutics, For: Dec 31
Form SCHEDULE 13D/A Tenaya Therapeutics, Filed by: COLUMN GROUP III, LP
Form 8-K Tenaya Therapeutics, For: Dec 11
Form 424B5 Tenaya Therapeutics,
Form 424B5 Tenaya Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.